Clinical Trial Update: Phase III Clinical Trial of Lot-to-lot Consistency of Recombinant Herpes Zoster Vaccine (CHO Cell). [Phase 3]

View source ↗

Summary

Phase III trial to evaluate lot-to-lot consistency of MAXVAX's recombinant herpes zoster vaccine produced in CHO cells; status is NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Zoster

Drugs mentioned

• Recombinant herpes zoster vaccine (CHO cell) (recombinant herpes zoster vaccine)

Snippet

Sponsor: MAXVAX Biotechnology Limited Liability Company | Conditions: Herpes Zoster | Phase 3 | Status: NOT_YET_RECRUITING